In vivo paracrine interaction between urokinase and its receptor

Effect on tumor cell invasion

Liliana Ossowski, Garfield Clunie, Maria Teresa Masucci, Francesco Blasi

Research output: Contribution to journalArticle

194 Citations (Scopus)

Abstract

Numerous studies have linked the production of increased levels of urokinase type plasminogen activator (uPA) with the malignant phenotype. It has also been shown that a specific cell surface receptor can bind uPA through a domain distinct and distant from the proteolytic domain. In an in vivo model of invasion, consisting of experimentally modified chorioallantoic membrane (CAM) of a chick embryo, only cells that concurrently expressed both uPA and a receptor for uPA, and in which the receptor was saturated with uPA, were efficient in invasion. To test whether uPA produced by one cell can, in a paracrine fashion, affect the invasive capacity of a receptor-expressing cell, we transfected LB6 mouse cells with human uPA (LB6[uPA]), or human uPA-receptor cDNA (LB6[uPAR]). LB6(uPA) cells released into the medium 1-2 Ploug units of human uPA per 106 cells in 24 h. The LB6(uPAR) cells expressed on their surface ∼12,000 high affinity (Kd 1.7 × 10-10 M) uPA binding sites per cell. Unlabeled LB6(uPA) and 125-IUdR-labeled LB6(uPAR) cells were coinoculated onto experimentally wounded and resealed CAMs and their invasion was compared to that of homologous mixtures of labeled and unlabeled LB6(uPAR) or LB6(uPA) cells. Concurrent presence of both cell types in the CAMs resulted in a 1.8-fold increase of invasion of the uPA-receptor expressing cells. A four-fold stimulation of invasion was observed when cells were cocultured in vitro, prior to in vivo inoculation. Enhancement of invasion was prevented in both sets of experiments by treatment with specific antihuman uPA antibodies, indicating that uPA was the main mediator of the invasion-enhancing, paracrine effect on the receptor-expressing cells.

Original languageEnglish
Pages (from-to)1107-1112
Number of pages6
JournalJournal of Cell Biology
Volume115
Issue number4
Publication statusPublished - Nov 1991

Fingerprint

Urokinase-Type Plasminogen Activator
Neoplasms
Urokinase Plasminogen Activator Receptors
Complementary DNA
Idoxuridine
Chorioallantoic Membrane
Cell Surface Receptors
Chick Embryo

ASJC Scopus subject areas

  • Cell Biology

Cite this

In vivo paracrine interaction between urokinase and its receptor : Effect on tumor cell invasion. / Ossowski, Liliana; Clunie, Garfield; Masucci, Maria Teresa; Blasi, Francesco.

In: Journal of Cell Biology, Vol. 115, No. 4, 11.1991, p. 1107-1112.

Research output: Contribution to journalArticle

Ossowski, Liliana ; Clunie, Garfield ; Masucci, Maria Teresa ; Blasi, Francesco. / In vivo paracrine interaction between urokinase and its receptor : Effect on tumor cell invasion. In: Journal of Cell Biology. 1991 ; Vol. 115, No. 4. pp. 1107-1112.
@article{6b96ecbc937d4272bc9d76af688a5283,
title = "In vivo paracrine interaction between urokinase and its receptor: Effect on tumor cell invasion",
abstract = "Numerous studies have linked the production of increased levels of urokinase type plasminogen activator (uPA) with the malignant phenotype. It has also been shown that a specific cell surface receptor can bind uPA through a domain distinct and distant from the proteolytic domain. In an in vivo model of invasion, consisting of experimentally modified chorioallantoic membrane (CAM) of a chick embryo, only cells that concurrently expressed both uPA and a receptor for uPA, and in which the receptor was saturated with uPA, were efficient in invasion. To test whether uPA produced by one cell can, in a paracrine fashion, affect the invasive capacity of a receptor-expressing cell, we transfected LB6 mouse cells with human uPA (LB6[uPA]), or human uPA-receptor cDNA (LB6[uPAR]). LB6(uPA) cells released into the medium 1-2 Ploug units of human uPA per 106 cells in 24 h. The LB6(uPAR) cells expressed on their surface ∼12,000 high affinity (Kd 1.7 × 10-10 M) uPA binding sites per cell. Unlabeled LB6(uPA) and 125-IUdR-labeled LB6(uPAR) cells were coinoculated onto experimentally wounded and resealed CAMs and their invasion was compared to that of homologous mixtures of labeled and unlabeled LB6(uPAR) or LB6(uPA) cells. Concurrent presence of both cell types in the CAMs resulted in a 1.8-fold increase of invasion of the uPA-receptor expressing cells. A four-fold stimulation of invasion was observed when cells were cocultured in vitro, prior to in vivo inoculation. Enhancement of invasion was prevented in both sets of experiments by treatment with specific antihuman uPA antibodies, indicating that uPA was the main mediator of the invasion-enhancing, paracrine effect on the receptor-expressing cells.",
author = "Liliana Ossowski and Garfield Clunie and Masucci, {Maria Teresa} and Francesco Blasi",
year = "1991",
month = "11",
language = "English",
volume = "115",
pages = "1107--1112",
journal = "Journal of Cell Biology",
issn = "0021-9525",
publisher = "Rockefeller University Press",
number = "4",

}

TY - JOUR

T1 - In vivo paracrine interaction between urokinase and its receptor

T2 - Effect on tumor cell invasion

AU - Ossowski, Liliana

AU - Clunie, Garfield

AU - Masucci, Maria Teresa

AU - Blasi, Francesco

PY - 1991/11

Y1 - 1991/11

N2 - Numerous studies have linked the production of increased levels of urokinase type plasminogen activator (uPA) with the malignant phenotype. It has also been shown that a specific cell surface receptor can bind uPA through a domain distinct and distant from the proteolytic domain. In an in vivo model of invasion, consisting of experimentally modified chorioallantoic membrane (CAM) of a chick embryo, only cells that concurrently expressed both uPA and a receptor for uPA, and in which the receptor was saturated with uPA, were efficient in invasion. To test whether uPA produced by one cell can, in a paracrine fashion, affect the invasive capacity of a receptor-expressing cell, we transfected LB6 mouse cells with human uPA (LB6[uPA]), or human uPA-receptor cDNA (LB6[uPAR]). LB6(uPA) cells released into the medium 1-2 Ploug units of human uPA per 106 cells in 24 h. The LB6(uPAR) cells expressed on their surface ∼12,000 high affinity (Kd 1.7 × 10-10 M) uPA binding sites per cell. Unlabeled LB6(uPA) and 125-IUdR-labeled LB6(uPAR) cells were coinoculated onto experimentally wounded and resealed CAMs and their invasion was compared to that of homologous mixtures of labeled and unlabeled LB6(uPAR) or LB6(uPA) cells. Concurrent presence of both cell types in the CAMs resulted in a 1.8-fold increase of invasion of the uPA-receptor expressing cells. A four-fold stimulation of invasion was observed when cells were cocultured in vitro, prior to in vivo inoculation. Enhancement of invasion was prevented in both sets of experiments by treatment with specific antihuman uPA antibodies, indicating that uPA was the main mediator of the invasion-enhancing, paracrine effect on the receptor-expressing cells.

AB - Numerous studies have linked the production of increased levels of urokinase type plasminogen activator (uPA) with the malignant phenotype. It has also been shown that a specific cell surface receptor can bind uPA through a domain distinct and distant from the proteolytic domain. In an in vivo model of invasion, consisting of experimentally modified chorioallantoic membrane (CAM) of a chick embryo, only cells that concurrently expressed both uPA and a receptor for uPA, and in which the receptor was saturated with uPA, were efficient in invasion. To test whether uPA produced by one cell can, in a paracrine fashion, affect the invasive capacity of a receptor-expressing cell, we transfected LB6 mouse cells with human uPA (LB6[uPA]), or human uPA-receptor cDNA (LB6[uPAR]). LB6(uPA) cells released into the medium 1-2 Ploug units of human uPA per 106 cells in 24 h. The LB6(uPAR) cells expressed on their surface ∼12,000 high affinity (Kd 1.7 × 10-10 M) uPA binding sites per cell. Unlabeled LB6(uPA) and 125-IUdR-labeled LB6(uPAR) cells were coinoculated onto experimentally wounded and resealed CAMs and their invasion was compared to that of homologous mixtures of labeled and unlabeled LB6(uPAR) or LB6(uPA) cells. Concurrent presence of both cell types in the CAMs resulted in a 1.8-fold increase of invasion of the uPA-receptor expressing cells. A four-fold stimulation of invasion was observed when cells were cocultured in vitro, prior to in vivo inoculation. Enhancement of invasion was prevented in both sets of experiments by treatment with specific antihuman uPA antibodies, indicating that uPA was the main mediator of the invasion-enhancing, paracrine effect on the receptor-expressing cells.

UR - http://www.scopus.com/inward/record.url?scp=0026341460&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026341460&partnerID=8YFLogxK

M3 - Article

VL - 115

SP - 1107

EP - 1112

JO - Journal of Cell Biology

JF - Journal of Cell Biology

SN - 0021-9525

IS - 4

ER -